Compare KURA & LWLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KURA | LWLG |
|---|---|---|
| Founded | 2014 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Containers/Packaging |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 846.4M |
| IPO Year | 2015 | 2011 |
| Metric | KURA | LWLG |
|---|---|---|
| Price | $13.03 | $5.09 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $25.56 | N/A |
| AVG Volume (30 Days) | 2.2M | ★ 2.6M |
| Earning Date | 05-12-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.79 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,482,000.00 | $236,855.00 |
| Revenue This Year | $28.28 | N/A |
| Revenue Next Year | $106.37 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 25.24 | ★ 147.74 |
| 52 Week Low | $7.36 | $2.84 |
| 52 Week High | $13.90 | $18.71 |
| Indicator | KURA | LWLG |
|---|---|---|
| Relative Strength Index (RSI) | 64.67 | 33.54 |
| Support Level | $7.96 | $3.81 |
| Resistance Level | $13.90 | $5.65 |
| Average True Range (ATR) | 0.68 | 0.34 |
| MACD | 0.09 | -0.12 |
| Stochastic Oscillator | 73.57 | 5.81 |
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
Lightwave Logic Inc is a specialty materials and intellectual property company focused on the development and commercialization of proprietary electro-optic (EO) polymer materials designed to enable high-speed optical modulators for data communications and other photonic applications. Its Perkinamine family of EO polymers is designed for integration into silicon photonics (SiPh) and other photonic integrated circuit (PIC) platforms, supporting high-speed optical modulation with lower drive voltage requirements compared with some conventional silicon-based and III-V compound semiconductor approaches. The company operates as a single reportable segment.